Assessment of Use and Safety of Edaravone for Amyotrophic Lateral Sclerosis in the Veterans Affairs Health Care System

IMPORTANCE: Using real-world data, the US Department of Veterans Affairs (VA) initiated a surveillance evaluation of edaravone after its approval for amyotrophic lateral sclerosis (ALS) in 2017. The use and safety of edaravone for patients with ALS in the VA health care system remain to be assessed....

Descripción completa

Detalles Bibliográficos
Autores principales: Vu, Michelle, Tortorice, Kathryn, Zacher, Jennifer, Dong, Diane, Hur, Kwan, Zhang, Rongping, Good, Chester B., Glassman, Peter A., Cunningham, Francesca E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2020
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536587/
https://www.ncbi.nlm.nih.gov/pubmed/33017028
http://dx.doi.org/10.1001/jamanetworkopen.2020.14645

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536587/
https://www.ncbi.nlm.nih.gov/pubmed/33017028
http://dx.doi.org/10.1001/jamanetworkopen.2020.14645

Ejemplares similares